| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.292 | 2.743 | 1.805 | 2.873 | 7.228 | 11.457 | 14.059 | 15.224 | 16.790 | 17.411 |
| Total Income - EUR | 3.292 | 2.743 | 1.805 | 2.873 | 7.228 | 11.457 | 16.015 | 15.224 | 16.790 | 17.411 |
| Total Expenses - EUR | 2.881 | 2.603 | 1.934 | 2.354 | 4.447 | 4.587 | 12.650 | 12.648 | 16.995 | 18.737 |
| Gross Profit/Loss - EUR | 412 | 140 | -129 | 519 | 2.781 | 6.870 | 3.366 | 2.576 | -206 | -1.326 |
| Net Profit/Loss - EUR | 329 | 58 | -183 | 441 | 2.564 | 6.526 | 3.366 | 2.471 | -131 | -1.500 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biocore Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 3.147 | 5.655 | 9.573 | 7.524 | 5.780 | 7.236 |
| Current Assets | 4.772 | 3.441 | 3.010 | 3.463 | 5.017 | 8.357 | 1.284 | 1.303 | 3.624 | 2.709 |
| Inventories | 4.122 | 2.735 | 2.667 | 2.901 | 1.884 | 1.848 | 40 | 41 | 40 | 40 |
| Receivables | 351 | 398 | 23 | 0 | 303 | 0 | 0 | 0 | 706 | 1.293 |
| Cash | 299 | 308 | 320 | 561 | 2.831 | 6.508 | 1.244 | 1.263 | 2.878 | 1.376 |
| Shareholders Funds | -10.747 | -12.285 | -12.260 | -11.594 | -8.806 | -2.113 | 1.300 | 3.774 | 3.632 | 2.111 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 15.520 | 15.726 | 15.271 | 15.057 | 16.970 | 16.125 | 9.558 | 5.313 | 6.031 | 8.092 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8696 - 8696" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Biocore Srl